In females, there were concentration-related increases in the incidence of both hepatocellular adenomas and combined adenomas and carcinomas, which were significant at the highest concentration.
Chez les deux groupes, ces incidences étaient liées à la dose et étaient plus importantes à la concentration la plus élevée.